Affiliation:
1. KEMRI‐Wellcome Trust Research Programme (KWTRP) Kilifi Kenya
2. Department of Infectious Diseases Epidemiology London School of Hygiene and Tropical Medicine London UK
3. Ministry of Health Government of Kenya Nairobi Kenya
4. Nuffield Department of Medicine Oxford University Oxford UK
5. School of Life Sciences and the Zeeman Institute for Systems Biology & Infectious Disease Epidemiology Research (SBIDER) University of Warwick Coventry UK
Abstract
AbstractBackgroundWe estimated the secondary attack rate of SARS‐CoV‐2 among household contacts of PCR‐confirmed cases of COVID‐19 in rural Kenya and analysed risk factors for transmission.MethodsWe enrolled incident PCR‐confirmed cases and their household members. At baseline, a questionnaire, a blood sample, and naso‐oropharyngeal swabs were collected. Household members were followed 4, 7, 10, 14, 21 and 28 days after the date of the first PCR‐positive in the household; naso‐oropharyngeal swabs were collected at each visit and used to define secondary cases. Blood samples were collected every 1–2 weeks. Symptoms were collected in a daily symptom diary. We used binomial regression to estimate secondary attack rates and survival analysis to analyse risk factors for transmission.ResultsA total of 119 households with at least one positive household member were enrolled between October 2020 and September 2022, comprising 503 household members; 226 remained in follow‐up at day 14 (45%). A total of 43 secondary cases arose within 14 days of identification of the primary case, and 81 household members remained negative. The 7‐day secondary attack rate was 4% (95% CI 1%–10%), the 14‐day secondary attack rate was 28% (95% CI 17%–40%). Of 38 secondary cases with data, eight reported symptoms (21%, 95% CI 8%–34%). Antibody to SARS‐CoV‐2 spike protein at enrolment was not associated with risk of becoming a secondary case.ConclusionHouseholds in our setting experienced a lower 7‐day attack rate than a recent meta‐analysis indicated as the global average (23%–43% depending on variant), and infection is mostly asymptomatic in our setting.
Funder
National Institute for Health and Care Research
Wellcome Trust
Subject
Infectious Diseases,Public Health, Environmental and Occupational Health,Pulmonary and Respiratory Medicine,Epidemiology